Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.mad.2020.111357

http://scihub22266oqcxt.onion/10.1016/j.mad.2020.111357
suck pdf from google scholar
32949594!7494491!32949594
unlimited free pdf from europmc32949594    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32949594      Mech+Ageing+Dev 2020 ; 192 (ä): 111357
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The conundrum of human immune system "senescence" #MMPMID32949594
  • Pawelec G; Bronikowski A; Cunnane SC; Ferrucci L; Franceschi C; Fulop T; Gaudreau P; Gladyshev VN; Gonos ES; Gorbunova V; Kennedy BK; Larbi A; Lemaitre JF; Liu GH; Maier AB; Morais JA; Nobrega OT; Moskalev A; Rikkert MO; Seluanov A; Senior AM; Ukraintseva S; Vanhaelen Q; Witkowski J; Cohen AA
  • Mech Ageing Dev 2020[Dec]; 192 (ä): 111357 PMID32949594show ga
  • There is a great deal of debate on the question of whether or not we know what ageing is (Ref. Cohen et al., 2020). Here, we consider what we believe to be the especially confused and confusing case of the ageing of the human immune system, commonly referred to as "immunosenescence". But what exactly is meant by this term? It has been used loosely in the literature, resulting in a certain degree of confusion as to its definition and implications. Here, we argue that only those differences in immune parameters between younger and older adults that are associated in some definitive manner with detrimental health outcomes and/or impaired survival prospects should be classed as indicators of immunosenescence in the strictest sense of the word, and that in humans we know remarkably little about their identity. Such biomarkers of immunosenescence may nonetheless indicate beneficial effects in other contexts, consistent with the notion of antagonistic pleiotropy. Identifying what could be true immunosenescence in this respect requires examining: (1) what appears to correlate with age, though generality across human populations is not yet confirmed; (2) what clearly is part of a suite of canonical changes in the immune system that happen with age; (3) which subset of those changes accelerates rather than slows aging; and (4) all changes, potentially population-specific, that accelerate agig. This remains an immense challenge. These questions acquire an added urgency in the current SARS-CoV-2 pandemic, given the clearly greater susceptibility of older adults to COVID-19.
  • |*COVID-19/epidemiology/immunology/pathology/therapy[MESH]
  • |*Immunosenescence[MESH]
  • |*Pandemics[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Biomarkers[MESH]
  • |Humans[MESH]
  • |Middle Aged[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box